Cellectis S.A.
CLLS
$3.59
$0.092.57%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.32M | 588.00K | -23.74M | -18.13M | 5.92M |
| Total Depreciation and Amortization | 3.88M | 5.01M | 5.02M | 4.93M | 5.07M |
| Total Amortization of Deferred Charges | 1.23M | -- | -- | -- | 758.00K |
| Total Other Non-Cash Items | 12.23M | 9.57M | 20.67M | 7.26M | -17.06M |
| Change in Net Operating Assets | -1.37M | -16.74M | -12.27M | -11.22M | 5.26M |
| Cash from Operations | -10.36M | -1.57M | -10.31M | -17.16M | -47.00K |
| Capital Expenditure | -479.00K | -1.18M | -305.00K | -395.00K | -550.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.93M | -2.26M | -52.41M | 4.62M | -16.11M |
| Cash from Investing | 22.45M | -3.44M | -52.72M | 4.22M | -16.66M |
| Total Debt Issued | -- | -- | -- | -- | 6.88M |
| Total Debt Repaid | -4.07M | -4.10M | -4.08M | -3.94M | -3.74M |
| Issuance of Common Stock | 44.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -110.00K | -158.00K | -193.00K | -151.00K | -216.00K |
| Cash from Financing | -4.14M | -4.26M | -4.27M | -4.09M | 2.93M |
| Foreign Exchange rate Adjustments | 1.34M | 1.71M | -529.00K | 1.41M | -2.06M |
| Miscellaneous Cash Flow Adjustments | -1.00K | 1.00K | -- | -- | 2.00K |
| Net Change in Cash | 9.29M | -7.57M | -67.83M | -15.62M | -15.84M |